聯創股份(300343.SZ)高開10.55% 寧德時代擬向公司採購鋰電池級PVDF和R142b產品
格隆匯12月13日丨聯創股份(300343.SZ)跳空高開10.55%報22元,市值253億元。公司昨晚公吿,與寧德時代於12月11日簽訂了《合作框架協議》,約定在協議有效期內,寧德時代向公司採購鋰電池級PVDF和R142b產品。R142b的採購數量為:2021年12月底前合計不低於1700噸;2022年度不低於7200噸。鋰電池級PVDF的採購量依據乙方屆時的生產量確定。協議有效期自簽訂之日起至2024年12月31日終止。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.